FDA reorganization is crucial to address complexity of products

09/9/2013 | Forbes

The FDA and Commissioner Dr. Margaret Hamburg deserve credit for initiating a task force that will work on plans to change the agency's structure, processes and functions, former FDA official Dr. Scott Gottlieb writes. To reflect the increasingly cross-functional complexity of the products that the FDA regulates, the agency is going to need to reorganize its executive units, he writes.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA